BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19377418)

  • 21. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years.
    Stratelis G; Jakobsson P; Molstad S; Zetterstrom O
    Br J Gen Pract; 2004 Mar; 54(500):201-6. PubMed ID: 15006126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a population-based screening questionnaire for COPD.
    Calverley PM; Nordyke RJ; Halbert RJ; Isonaka S; Nonikov D
    COPD; 2005 Jun; 2(2):225-32. PubMed ID: 17136949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers.
    Rasmussen T; Køber L; Pedersen JH; Dirksen A; Thomsen LH; Stender S; Brodersen J; Groen J; Ashraf H; Kofoed KF
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1159-66. PubMed ID: 23639550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VitalQPlus: a potential screening tool for early diagnosis of COPD.
    Sui CF; Ming LC; Neoh CF; Ibrahim B
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1613-22. PubMed ID: 26316735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COPD screening efforts in primary care: what is the yield?
    Tinkelman DG; Price D; Nordyke RJ; Halbert RJ
    Prim Care Respir J; 2007 Feb; 16(1):41-8. PubMed ID: 17297526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early detection of COPD in a high-risk population using spirometric screening.
    Zieliñski J; Bednarek M;
    Chest; 2001 Mar; 119(3):731-6. PubMed ID: 11243950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalence.
    Kainu A; Rouhos A; Sovijärvi A; Lindqvist A; Sarna S; Lundbäck B
    Scand J Public Health; 2013 Aug; 41(6):570-8. PubMed ID: 23599377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom-based questionnaire for identifying COPD in smokers.
    Price DB; Tinkelman DG; Halbert RJ; Nordyke RJ; Isonaka S; Nonikov D; Juniper EF; Freeman D; Hausen T; Levy ML; Ostrem A; van der Molen T; van Schayck CP
    Respiration; 2006; 73(3):285-95. PubMed ID: 16330875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Spirometry is a good method for detecting and monitoring chronic obstructive pulmonary disease in high-risk smokers in primary health care].
    Clotet J; Gómez-Arbonés X; Ciria C; Albalad JM
    Arch Bronconeumol; 2004 Apr; 40(4):155-9. PubMed ID: 15030729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early, targeted population based screening for COPD. Preliminary study].
    Pływaczewski R; Bednarek M; Górecka D; Puścińska E; Nowiński A; Zieliński J
    Pneumonol Alergol Pol; 1999; 67(9-10):416-21. PubMed ID: 10808385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of chronic obstructive pulmonary disease in Cyprus: a population-based study.
    Zachariades AG; Zachariadou T; Adamide T; Anagnostopoulou U; Georgiou A; Gourgoulianis KI
    COPD; 2012 Jun; 9(3):259-67. PubMed ID: 22432899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seven-year cumulative incidence of COPD in an age-stratified general population sample.
    Lindberg A; Eriksson B; Larsson LG; Rönmark E; Sandström T; Lundbäck B
    Chest; 2006 Apr; 129(4):879-85. PubMed ID: 16608933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A test for early detection of COPD].
    Czajkowska-Malinowska M; Zieliński J
    Pneumonol Alergol Pol; 2000; 68(5-6):207-12. PubMed ID: 11004857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary pulmonary function screening identifies high rates of undiagnosed asymptomatic chronic obstructive pulmonary disease.
    Wang S; Gong W; Tian Y
    Chron Respir Dis; 2016 May; 13(2):137-43. PubMed ID: 26869578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
    Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.